Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-04-18
2006-04-18
Ewoldt, G. R. (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S387500, C530S387200, C530S388730, C530S391100, C530S391300, C435S810000
Reexamination Certificate
active
07030228
ABSTRACT:
The invention provides antigen-binding fragments specific for dendritic cells and effective in treatment and/or diagnosing a variety of disorders. Methods of use are also provided as are methods for screening for additional such antigen-binding fragments and the products obtained thereby.
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4754065 (1988-06-01), Levenson et al.
patent: 4800159 (1989-01-01), Mullis et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5643786 (1997-07-01), Cohen et al.
patent: 5750119 (1998-05-01), Srivastava
patent: 5788963 (1998-08-01), Murphy et al.
patent: 5789650 (1998-08-01), Lonberg et al.
patent: 5876917 (1999-03-01), Hart
patent: 5972627 (1999-10-01), Galy
patent: 5985660 (1999-11-01), Galy
patent: 5994126 (1999-11-01), Steinman et al.
patent: 6004807 (1999-12-01), Banchereau et al.
patent: 6008004 (1999-12-01), Olweus et al.
patent: 6010905 (2000-01-01), Cohen et al.
patent: 6015554 (2000-01-01), Galy
patent: 6017527 (2000-01-01), Maraskovsky et al.
patent: 6046158 (2000-04-01), Ariizumi et al.
patent: 6255458 (2001-07-01), Lonberg et al.
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 0329400 (1993-09-01), None
patent: 922758 (1999-06-01), None
patent: WO 91/13632 (1991-09-01), None
patent: WO93/07286 (1993-04-01), None
patent: WO 93/20185 (1993-10-01), None
patent: WO 95/12409 (1995-05-01), None
patent: WO 96/07097 (1996-03-01), None
patent: WO96/10411 (1996-04-01), None
patent: WO 96/28732 (1996-09-01), None
patent: WO97/02342 (1997-01-01), None
patent: WO 97/03186 (1997-01-01), None
patent: WO97/06821 (1997-02-01), None
patent: WO97/10000 (1997-03-01), None
patent: WO97/10001 (1997-03-01), None
patent: WO 97/24447 (1997-07-01), None
patent: WO 97/29182 (1997-08-01), None
patent: WO 98/14561 (1998-04-01), None
patent: WO98/15579 (1998-04-01), None
patent: WO98/23735 (1998-06-01), None
patent: WO98/28332 (1998-07-01), None
patent: WO 98/28332 (1998-07-01), None
patent: WO98/34641 (1998-08-01), None
patent: WO98/34642 (1998-08-01), None
patent: WO 98/46785 (1998-10-01), None
patent: WO 99/02562 (1999-03-01), None
patent: WO 99/21997 (1999-05-01), None
patent: WO 99/43350 (1999-09-01), None
patent: WO 99/47646 (1999-09-01), None
patent: WO 99/57266 (1999-11-01), None
patent: WO 99/63050 (1999-12-01), None
patent: WO 00/06588 (2000-02-01), None
patent: WO 00/08191 (2000-02-01), None
patent: WO 00/09151 (2000-02-01), None
patent: WO 00/18803 (2000-04-01), None
patent: WO 00/35949 (2000-06-01), None
patent: WO 01/72773 (2001-10-01), None
Bagot et al. (1997) “CD101 is expressed by skin dendritic cells” Tiss. Ant. 50: 439-448.
Brossart et al. (1997) “Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL” J. Immunol. 158:3270-3276.
de Saint-Vis et al. (1998) “The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation” J. Immunol. 160:1666-1676.
Dzionek et al. (2000) “BDCA-2, BDCA-3, and BDCA-4:three novel markers for distinct subsets of dendritic cells in human peripheral blood” 7th Workshop and Conference on human Leucocyte Differentiation Antigens; Harrogate, England, UK, 55(suppl. 1):55-56.
Engels et al. (1999) “Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells” Proc. Natl. Acad. Sci. USA 96:10332-10337.
Everson et al. (1993) “Dendritic cells regulate Th1 versus Th2 responses” International Congress on the Regulation of Leukocyte Production and Immune Function Held at the Joint Meeting of the Australasian Society for Leukocyte Biology; Sydney Australia; abstract J. Leuc. Biol. suppl. p. 72.
Fitzgerald-Bocarsly et al. (1999) “Virally—responsive IFN α producing cells in human blood and tonsil are CD11C-/CD123+ cells identical to precursors of type two dendritic cells (pDC2)” J. Interfer. Cyt. Res. 19(suppl. 1):S117.
Larregina et al. (1997) “Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants” Immunol. 91:303-313.
Liu et al. (1991) “The enhancing effect of calcium ionophore A23187 on the accessory function of mouse dendritic cells” Chemical Abstracts XP002047046 abstract.
Luft et al. (1998) “Type I IFNs enhance the terminal differentiation of dendritic cells” J Immunol. 161:1947-1953.
Muzny et al. (1999) Database EMBL online ID AC006517.
Rovere et al. (1998) “Dendritic cells preferentially internalize apoptotic cells opsonized by anti-β2-glycoprotein I antibodies” J Autoimmun. 11:403-411.
Rubartelli et al. (1997) “The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium” Eur. j. Immunol. 27:1893-1900.
Schmitt et al. (1987) “Antigenic thymus-epidermis relationships” Dermatologica 175:109-120.
Soler et al. (1989) “Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendrictic cells/Langerhans cells” Am. Respir. Dis. 139:1112-1117.
Theodorou et al. (1990) “CD1 stimulation of human T cell lines induces a rapid increase in the intracellular free Ca2+concentration and the production of IL-2” Immunol. 144:2518-2523.
Tüting et al. (1998) “Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α” J. Immunol. 160:1139-1147.
Valladeau et al. (1998) “A monoclonal antibody against Langerin, a protein specific of Langerhans cells, is internalized in coated pits and Birbeck granule” J. Leuk. Biol. No. Suppl. 02, p. 1.
U.S. Appl. No. 60/192,934, filed Mar. 29, 2000, Werner et al.
U.S. Appl. No. 60/205,026, filed May 18, 2000, Mourier.
U.S. Appl. No. 60/205,767, filed May 19, 2000, Werner et al.
U.S. Appl. No. 60/205,769, filed May 19, 2000, Jaritz et al.
Bagot, M. et al. (1997). “CD101 is Expressed by Skin Dendritic Cells: Role in T-Lymphocyte Activation,”Tissue Antigens50(5): 439-448.
Brossart, P. et al. (1997). “Virus-Mediated Delivery of Antigenic Epitopes into Dendritic Cells as a Means to Induce CTL,”J. Immunol.155(158):3270-3276.
de Saint-Vis, B. et al. (1998). “The Cytokine Profile Expressed by Human Dendritic Cells is Dependent on Cell Subtype and Mode of Activation,”J. Immunol.160(4):1666-1676.
Dzionek, A. et al. (2000). “BDCA-2, BDCA-3 and BCDA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood,”J. Immunol..165:6037-6046.
Dzionek, A. et al. (2000). “BDCA-2, BDCA-3 and BCDA-4: Three Novel Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood,”Tissue Antigens55(Supp. 1):55-56.
Engels, F.H. et al. (1999). “Calcium Signaling Induces Acquisition of Dendritic Cell Characteristics in Chronic Myelogenous Leukemia Myeloid Progenitor Cells,”PNAS96(18):10332-10337.
Everson, M.P. et al. (1993). “Dendritic Cells Regulate Th1 Versus Th3 Responses,”J. Leukocyte Biology(International Congress on the Regulation of Leukocyte Production and Immune Funtion held at the Joint Meeting of the Australiasian Society for Immunology and Society for Leukocyte Biology). p. 72 (Abstract No. 237).
Fitzgerald-Bocarsly, P. et al. (1999). “Virally-Responsive IFN-alpha Producing Cells in Human Blood and Tonsil are CD11C/CD123+Cells Identical to Precursors of Type Two Dendritic Cells (pDC2),”J. Interferon and Cytokine Rese
Buck David William
Dzionek Andrzej
Schmitz Juergen
Ewoldt G. R.
Miltenyi Biotec GmbH
LandOfFree
Antigen-binding fragments specific for dendritic cells,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen-binding fragments specific for dendritic cells,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen-binding fragments specific for dendritic cells,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3606142